Abstract
Infections are common in systemic lupus erythematosus (SLE), and remain a source of mortality. The types of infections (such as pneumonia, urinary tract infection, cellulitis, and sepsis) in SLE patients are similar to the general population and include the same pathogens (Gram-positive and Gram-negative). SLE patients may also develop opportunistic infections, especially when treated with immunosuppressive agents. As a high-risk population, identification and treatment of chronic infections such as tuberculosis, hepatitis B, or human immunodeficiency virus (HIV), are important prior to the institution of immunosuppression to prevent reactivation or exacerbation of the infection. A common caveat is to distinguish between a lupus flare and an acute infection; judicious use of corticosteroids and cytotoxic drugs is critical in limiting infectious complications. The risk factors associated with susceptibility to disease include severe flares, active renal disease, treatment with moderate or high doses of corticosteroids and/or immunosuppressive agents, and others. Genetic factors (complement deficiencies, mannose-binding lectin, Fcgarama III, granulocyte macrophage colony-stimulating factor [GM-CSF], osteopontin) may predispose certain SLE patients to develop infections. Parameters including C-reactive protein (CRP) and adhesion molecules may help to differentiate an infectious disease from an exacerbation of the disease. Finally, the mechanism of molecular mimicry by specific microbial agents may play a role in the induction of SLE.
Similar content being viewed by others
References
Petri, M. (1998), Rheum. Dis. Clin. N. Am. 24, 423–456.
Fessler, B. J. (2002), Best Pract. Res. Clin. Rheumatol. 16, 281–291.
Bouza, E., Moya, J. G., and Munoz, P. (2001), Infect. Dis. Clin. N. Am. 15, 335–361.
Gladman, D. D., Hussain, F., Ibanez, D., et al. (2002), Lupus 11, 234–239.
Cervera, R., Khamashta, M. A., Font, J., et al. (1999), Medicine (Baltimore), 78, 167–175.
Noel, V., Lortholary, O., Casassus, P., et al. (2001), Ann. Rheum. Dis. 60, 1141–1144.
Zonana-Nacach, A., Camargo-Coronel, A., Yanez, P., et al. (2001), Lupus 10, 505–510.
Li, Z., Chen, L., Tao, R., et al. (1998), Chin. Med. J. (Engl.) 111, 913–916.
Wongchinsri, J., Tantawichien, T., Osiri, M., et al., (2002), J. Med. Assoc. Thail. 85(Suppl 1), S34-S39.
Bouza, E., Moya, J. G., Munoz, P., et al., (2000), P R Health Sci. J. 19, 335–339.
Alarcon, G. S., McGwin, G. Jr., Bastian, H. M., et al., (2001), Arthritis Rheum. 45, 191–220.
Bellomio, V., Spindler, A., Lucero, E., et al., (2000), Lupus 9, 377–381.
Jacobsen, S., Petersen, J., Ullman, S., et al., (1999), Scand. J. Rheumatol. 28, 75–80.
Tsao, C. H., Chen, C. Y., Ou, L. S., and Huang, J. L. (2002), J. Rheumatol. 29, 1214–1218.
Lim, E., Koh, W. H., Loh, S. F., Lam, M. S., and Howe, H. S. (2001), Lupus 10, 87–92.
El-Roiey, A., Gross, W. L., Ludeman, J., et al., (1986), Immunol. Lett. 12, 313–319.
El-Roeiy, A., Sela, O., Isenberg, D., et al., (1987), Clin. Exp. Immunol. 67, 505–515.
George, J. and Shoenfeld, Y. (1995), Lupus 4, 333–335.
Kowal, C., Weinstein, A., and Diamond, B. (1999), Eur. J. Immunol. 29, 1901–1911.
Yun, J. E., Lee, S. W., Kim, T. H., et al., (2002), Clin, Exp. Rheumatol. 20, 127–132.
Balakrishnan, C., Mangat, G., Mittal, G., et al., (1998), J. Assoc. Physicians India 46, 682–683.
Hernandez-Cruz, B., Sifuentes-Osornio, J., Poncede-Leon Rosales, S., et al. (1999), Clin. Exp. Rheumatol. 17, 289–296.
Gordon, M. M., Wilson, H. E., Duthie, F.R., et al., (2002), Rheumatology (Oxford) 41, 685–690.
Sela, O., el-Roeiy, A., Isenberg, D., et al., (1987), Arthritis Rheum. 30, 50–56.
Tasneem, S., Islam, N., and Ali, R. (2001), Microbiol. Immunol. 45, 841–846.
Seta, N., Shimizu, T., Nawata, M., et al., (2002), Rheumatology 41, 1072–1073.
Lyngberg, K. K., Vennervald, B. J., Bygbjerg, I. C., et al. (1992), Ann. Med. 24, 337–340.
Zamir, D., Amar, M., Groisman, G., et al., (1999), Mayo Clin. Proc. 74, 575–578.
Baykal, Y., Saglam, K., and Caliskaner, Z. (1998), J. Rheumatol. 25, 2038–2039.
Hsu, T. C. and Tsay, G. J. (2001), Rheumatology (Oxford) 40, 152–157.
Barash, J., Dushnitzky, D., Sthoeger, D., et al., (2002), Isr. Med. Assoc. J. 4, 763–765.
Diaz, F., Collazos, J., Mendoza, F., et al., (2002), Clin. Microbiol. Infect. 8, 115–117.
Trapani, S., Ermini, M., and Falcini, F. (1999), Semin. Arthritis Rheum. 28, 319–325.
Sekigawa, I., Nawata, M., Seta, N., et al. (2002), Clin. Exp. Rheumatol. 20, 559–564.
Gharavi, A. E., Pierangeli, S. S., Espinola, R. G., et al. (2002), Arthritis Rheum. 46, 545–552.
McClain, M. T., Harley, J. B., and James, J. A. (2001), Front Biosci. 6, E137-E147.
James, J. A., Neas, B. R., Moser, K. L., et al., (2001), Arthritis Rheum. 44, 1122–1126.
Zandman-Goddard, G. and Shoenfeld, Y. (2002), Autoimmunity Reviews 1, 329–337.
Barthel, H. R. and Wallace, D. J. (1993), Semin. Arthritis Rheum. 23, 1–7.
Pontesilli, O., Kerkhof-Grade, S., Notermans, D. W., et al. (1999), J. Infect. Dis. 180, 76–86.
Erdal, D., Lipsky, P. E., and Berggren, R. E. (2000), J. Rheumatol. 27 2711–2714.
Palacios, R., Santos, J., Valdivielso, P., et al., (2002), Lupus 1, 60–63.
Fox, R. A. and Isenberg, D. A. (1997), Arthritis Rheum. 40, 1168–1172.
Diri, E., Lipsky, P. E., and Berggren, R. E. (2000), J. Rheumatol. 27, 2711–2714.
Gonzalez, C. M., Lopez-Longo, F. J., Samson, J., et al., (1998), AIDS Patient Care STDS 12, 21–28.
Adelman, M. K. and Marchalonis, J. J. (2002), Clin. Immunol. 102, 107–116.
Garred, P., Voss, A., Madsen, H. O., et al., (2001), Genes Immun. 2 442–450.
Holers, V. M. (1999), Arthritis Rheum. 42, 2023–2025.
Amadei, N., Baracho, G. V., Nudelman, V., et al., (2001), Scand. J. Immunol. 53, 615–621.
Forton, A. C., Petri, M. A., Goldman, D., and Sullivan, K. E. (2002), Hum. Mutat. 19, 459.
Suh, C. H., Jeong, Y. S., Park, H. C., Lee, C. H., Lee, J., Song, C. H., et al. (2001), Clin. Exp. Rheumatol. 19, 191–194.
Roy, S. and Tan, K. T. (2001), Rheumatology (Oxford) 40, 349–350.
Hellmich, B., Csernok, E., de Haas, M., et al., (2002), Am. J. Med. 113, 134–139.
Egerer, K., Feist, E., Rohr, U., et al., (2000), Lupus 9, 614–621.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zandman-Goddard, G., Shoenfeld, Y. SLE and infections. Clinic Rev Allerg Immunol 25, 29–39 (2003). https://doi.org/10.1385/CRIAI:25:1:29
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:25:1:29